- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Leverage Leaders
Taiwanese Pharmaceuticals & Biotech Leverage Leaders
Results
2
0 new
2 companies
PharmaEssentia
Market Cap: NT$262.2b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$709.00
7D
-2.2%
1Y
20.9%
Caliway Biopharmaceuticals
Market Cap: NT$254.2b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$164.00
7D
2.5%
1Y
72.5%